Is Altimmune Inc (ALT) worth investing in despite its undervalued state?

While Altimmune Inc has underperformed by -1.31%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ALT fell by -39.95%, with highs and lows ranging from $14.84 to $5.28, whereas the simple moving average fell by -6.90% in the last 200 days.

On January 08, 2025, Stifel started tracking Altimmune Inc (NASDAQ: ALT) recommending Buy. A report published by UBS on November 12, 2024, Initiated its previous ‘Buy’ rating for ALT. Goldman Initiated an Neutral rating on January 24, 2024, and assigned a price target of $13. Goldman March 22, 2023d its ‘Buy’ rating to ‘Neutral’ for ALT, as published in its report on March 22, 2023. Goldman’s report from December 01, 2022 suggests a price prediction of $20 for ALT shares, giving the stock a ‘Buy’ rating. Jefferies also rated the stock as ‘Buy’.

Analysis of Altimmune Inc (ALT)

Further, the quarter-over-quarter decrease in sales is -98.62%, showing a negative trend in the upcoming months.

In order to gain a clear picture of Altimmune Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -72.96% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 16.87, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 3.22M can be a very valuable indicator of volatility for ALT stock. On a monthly basis, the volatility of the stock is set at 6.75%, whereas on a weekly basis, it is put at 5.90%, with a loss of -6.61% over the past seven days. Furthermore, long-term investors anticipate a median target price of $22.25, showing growth from the present price of $6.78, which can serve as yet another indication of whether ALT is worth investing in or should be passed over.

How Do You Analyze Altimmune Inc Shares?

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.84%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 56.02% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

ALT shares are owned by institutional investors to the tune of 56.02% at present.

Related Posts